BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Fosun Pharma And Pfizer Enter Global GLP One Receptor Agonist Licensing Deal For YP05002

Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao Pharma"), Shanghai Fosun Pharmaceutical Industrial Devel...

December 10, 2025 | News

ChemLex Establishes Global Headquarters And Self Driving Laboratory In Singapore With USD 45 Million Funding

ChemLex, a next-generation AI-for-science company,announced the establishment of its global headquarters and self-driving laboratory in Singapore, alo...

December 09, 2025 | News

GC Biopharma Ships World First Recombinant Anthrax Vaccine For National Stockpile

GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced the first shipment of BARYTHRAX inj., the world's first recombinant a...

December 09, 2025 | News

Biocytogen Announces FDA IND Clearance for IDE034 Bispecific B7H3 PTK7 ADC Licensed to IDEAYA Biosciences

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision o...

December 08, 2025 | News

Ajinomoto CELLiST Korea Launches New CELLiST AAV Production Supplement 1 to Boost Viral Vector Productivity

Ajinomoto Co in Tokyo collaborated with its United States based consolidated subsidiary Forge Biologics, a leading CDMO in adeno associated virus developme...

December 04, 2025 | News

Zydus and RK Pharma Partner on Innovative Sterile Injectable for Oncology Supportive Care

Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, announced that it has entered into an e...

November 27, 2025 | News

eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing

eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, throug...

November 27, 2025 | News

Exyte Completes Full Integration of Pharmaplan To Strengthen European Leadership in Biopharma Engineering

Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, has completed the integration of Pharmaplan, marking the full tran...

November 26, 2025 | News

Sanofi and AstraZeneca’s Beyfortus Gains Malaysia Approval to Protect All Infants from RSV

Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying...

November 25, 2025 | News

Global Leaders Signal a Confident New Chapter for Cell and Gene Therapy at GenScript Global Forum London 2025

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...

November 24, 2025 | News

Aspen Neuroscience Secures $115 Million Series C to Advance Personalised Cell Therapy for Parkinson’s Disease

Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, announced the closing of a $115 millio...

November 21, 2025 | News

CRScube Acquires Mednet to Build a Unified Global eClinical Platform Across Asia and North America

CRScube has announced the successful acquisition of Mednet, marking a key milestone in its global strategic growth and expansion into the North Ameri...

November 20, 2025 | News

Nona Biosciences Enters License Agreement with Pfizer to Advance Global Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea t...

November 20, 2025 | News

Tsingke Biotech Showcases Breakthrough Speed in Protein and Antibody Development at PEGS Europe 2025

At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest ac...

November 20, 2025 | News

Stay Connected